» Articles » PMID: 25621117

Advances and Challenges in the Differentiation of Pluripotent Stem Cells into Pancreatic β Cells

Overview
Date 2015 Jan 27
PMID 25621117
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Pluripotent stem cells (PSCs) are able to differentiate into several cell types, including pancreatic β cells. Differentiation of pancreatic β cells depends on certain transcription factors, which function in a coordinated way during pancreas development. The existing protocols for in vitro differentiation produce pancreatic β cells, which are not highly responsive to glucose stimulation except after their transplantation into immune-compromised mice and allowing several weeks for further differentiation to ensure the maturation of these cells in vivo. Thus, although the substantial improvement that has been made for the differentiation of induced PSCs and embryonic stem cells toward pancreatic β cells, several challenges still hindering their full generation. Here, we summarize recent advances in the differentiation of PSCs into pancreatic β cells and discuss the challenges facing their differentiation as well as the different applications of these potential PSC-derived β cells.

Citing Articles

In Vitro Maturation of Human Pluripotent Stem Cell-Derived Myotubes.

Mondragon-Gonzalez R, Selvaraj S, Perlingeiro R Methods Mol Biol. 2023; 2640:129-142.

PMID: 36995592 DOI: 10.1007/978-1-0716-3036-5_10.


Accelerated neuronal aging ∼melting watch ∼.

Inagaki E, Yoshimatsu S, Okano H Front Aging Neurosci. 2022; 14:868770.

PMID: 36016855 PMC: 9397486. DOI: 10.3389/fnagi.2022.868770.


Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges.

Silva I, Kimura C, Colantoni V, Sogayar M Stem Cell Res Ther. 2022; 13(1):309.

PMID: 35840987 PMC: 9284809. DOI: 10.1186/s13287-022-02977-y.


Recapitulating pancreatic cell-cell interactions through bioengineering approaches: the momentous role of non-epithelial cells for diabetes cell therapy.

Ghezelayagh Z, Zabihi M, Kazemi Ashtiani M, Ghezelayagh Z, Lynn F, Tahamtani Y Cell Mol Life Sci. 2021; 78(23):7107-7132.

PMID: 34613423 PMC: 11072828. DOI: 10.1007/s00018-021-03951-2.


Improved Differentiation of hESC-Derived Pancreatic Progenitors by Using Human Fetal Pancreatic Mesenchymal Cells in a Micro-scalable Three-Dimensional Co-culture System.

Ghezelayagh Z, Zabihi M, Zarkesh I, Goncalves C, Larsen M, Hagh-Parast N Stem Cell Rev Rep. 2021; 18(1):360-377.

PMID: 34586606 DOI: 10.1007/s12015-021-10266-z.


References
1.
Evans M . Discovering pluripotency: 30 years of mouse embryonic stem cells. Nat Rev Mol Cell Biol. 2011; 12(10):680-6. DOI: 10.1038/nrm3190. View

2.
Yakhnenko I, Wong W, Katkov I, Itkin-Ansari P . Cryopreservation of human insulin expressing cells macro-encapsulated in a durable therapeutic immunoisolating device theracyte. Cryo Letters. 2012; 33(6):518-31. View

3.
Tian T, Meng A . Nodal signals pattern vertebrate embryos. Cell Mol Life Sci. 2006; 63(6):672-85. PMC: 11136398. DOI: 10.1007/s00018-005-5503-7. View

4.
Bruin J, Erener S, Vela J, Hu X, Johnson J, Kurata H . Characterization of polyhormonal insulin-producing cells derived in vitro from human embryonic stem cells. Stem Cell Res. 2013; 12(1):194-208. DOI: 10.1016/j.scr.2013.10.003. View

5.
Lavon N, Yanuka O, Benvenisty N . The effect of overexpression of Pdx1 and Foxa2 on the differentiation of human embryonic stem cells into pancreatic cells. Stem Cells. 2006; 24(8):1923-30. DOI: 10.1634/stemcells.2005-0397. View